Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency
Am J Respir Crit Care Med 2020; 202(7): 973-982
Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema
Am J Respir Crit Care Med 2020; 202(7): 983-995
Aerosol Generation from the Respiratory Tract with Various Modes of Oxygen Delivery
Am J Respir Crit Care Med 2020; 202(8): 1115-1124
Dibutyl Phthalate Augments Allergen-induced Lung Function Decline and Alters Human Airway Immunology
A Randomized Crossover Study
Am J Respir Crit Care Med 2020; 202（5）: 672‒680
Bronchial Rheoplasty for Treatment of Chronic Bronchitis
Twelve-Month Results from a Multicenter Clinical Trial
Am J Respir Crit Care Med 2020; 202（5）: 681‒689
Lung Development Genes and Adult Lung Function
Am J Respir Crit Care Med 2020; 202（6）: 853‒865
Selected articles from AJRCCM. Copyright 2018 by the American Thoracic Society. All rights reserved. The ideas and opinions expressed in the American Journal of Respiratory and Critical Care Medicine (AJRCCM) or other associated publications do not necessarily reflect those of the American Thoracic Society (ATS). The authors, editors or ATS are not responsible for errors or omissions of articles published in print or online from AJRCCM or other associated ATS publications. Although great care has been taken in compiling the content of this publication, neither ATS or their servants are responsible or liable in any way for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising there from. Approved product information should be reviewed before prescribing. The mention of any product, service, or therapy in this publication should not be construed as an endorsement of the products mentioned. It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient. Readers are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, method, and duration of administration, or contraindications. Readers are also encouraged to contact the manufacturer with questions about the features or limitations of any products. ATS assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this publication or to any errors or omissions.
The translation is © 2018 American Thoracic Society. American Thoracic Society or Springer Healthcare takes no responsibility for the accuracy of the translation from the published English original and are not liable for any errors that may occur.